Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
1 other identifier
interventional
375
1 country
11
Brief Summary
A multi-center, double-blind, placebo-controlled out-patient, safety, tolerability, and pilot efficacy study of intramuscular AN-1792 in patients with mild to moderate Alzheimer's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Sep 2001
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2001
CompletedFirst Posted
Study publicly available on registry
August 6, 2001
CompletedStudy Start
First participant enrolled
September 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2003
CompletedSeptember 24, 2009
November 1, 2001
August 2, 2001
September 22, 2009
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (11)
Pivotal Research Centers
Peoria, Arizona, 85381, United States
21st Century Neurology
Phoenix, Arizona, 85013, United States
California Clinical Trials
Beverly Hills, California, 90211, United States
UCSD Medical Center
La Jolla, California, 92093, United States
Pharmacology Research Institute
Northridge, California, 91324-4625, United States
Baumel-Eisner Neuromedical Institute
Bay Harbor Islands, Florida, 33154, United States
Baumel-Eisner Neuromedical Institute
Boca Raton, Florida, 33486, United States
Baumel-Eisner Neuromedical Institute
Fort Lauderdale, Florida, 33321, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Clinical Pharmaceutical Trials, Inc.
Tulsa, Oklahoma, 74104, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 2, 2001
First Posted
August 6, 2001
Study Start
September 1, 2001
Study Completion
September 1, 2003
Last Updated
September 24, 2009
Record last verified: 2001-11